HRS Investment Holdings’s AbbVie ABBV Stock Holding History

HRS Investment Holdings’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-32,500	Closed	-$3M	–	5
2018 Q4	$3M	Sell	32,500 -27,500	-46%	-$2.42M	1.66%	9
2018 Q3	$5.67M	Hold	60,000	–	–	2.61%	3
2018 Q2	$5.56M	Hold	60,000	–	–	2.8%	3
2018 Q1	$5.68M	Buy	60,000 +17,500	+41%	+$1.92M	2.76%	3
2017 Q4	$4.11M	Sell	42,500 -2,500	-6%	-$236K	2.16%	3
2017 Q3	$4M	Sell	45,000 -5,000	-10%	-$381K	2.42%	4
2017 Q2	$3.63M	Buy	50,000 +5,000	+11%	+$336K	2.37%	4
2017 Q1	$2.93M	Hold	45,000	–	–	2.11%	4
2016 Q4	$2.82M	Sell	45,000 -2,500	-5%	-$153K	2.28%	6
2016 Q3	$3M	Hold	47,500	–	–	2.76%	6
2016 Q2	$2.94M	Sell	47,500 -12,500	-21%	-$762K	2.81%	5
2016 Q1	$3.43M	Sell	60,000 -15,000	-20%	-$836K	3.21%	2
2015 Q4	$4.44M	Buy	+75,000	New	+$4.32M	4.28%	2

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HRS Investment Holdings's ABBV Position: Q1 2019 in Review

HRS Investment Holdings sold out of AbbVie (ABBV) in Q1 2019, closing a stake of 32,500 shares — an estimated $3M sold.

HRS Investment Holdings first reported a position in ABBV in Q4 2015 and held it in 13 quarters. The position peaked at $5.68M in Q1 2018. 2,033 funds tracked by Wall St. Rank hold ABBV as of Q1 2019.

HRS Investment Holdings reported no remaining AbbVie position as of Q1 2019 after selling out during the quarter.
HRS Investment Holdings sold 32,500 AbbVie shares in Q1 2019, an estimated $3M.
HRS Investment Holdings first reported a position in AbbVie in Q4 2015 and held it in 13 quarters.
HRS Investment Holdings's AbbVie position peaked at $5.68M in Q1 2018.
2,033 funds tracked by Wall St. Rank held AbbVie as of Q1 2019.

Based on HRS Investment Holdings's 13F filing for Q1 2019, filed 15 May 2019.